Literature DB >> 12753726

Drug release characteristics of lipid based benzoporphyrin derivative.

Rubinah K Chowdhary1, Isha Shariff, David Dolphin.   

Abstract

PURPOSE: The purpose of this study was to examine the transfer of verteporfin (BPDMA) from its lipid based formulation to serum proteins.
METHODS: As a result of BPDMA being confined to the lipid phase, it was found that fluorescence from the photosensitizer was highly concentration quenched. This phenomenon was used to demonstrate rapid transfer of lipid-based drug to various plasma components such as albumin and lipoproteins. Gel electrophoresis was used to show transfer of drug to lipoproteins.
RESULTS: Loss of fluorescence quenching showed rapid transfer of the drug from its lipid based formulation to serum proteins. Gel electrophoresis showed that both the drug and phospholipid components were transferred to the lipoprotein fraction concurrently. The electrophoretic mobility of plasma lipoproteins was increased as a result of their interaction with lipid-based BPDMA. It was also shown that the lipid-based structures were readily destabilized in the presence of relatively low concentrations of plasma, and that liposomes of this lipid composition were highly unlikely to be found intact in the circulation following intravenous injection.
CONCLUSIONS: Verteporfin is rapidly transferred from its lipid based formulation to serum proteins. This rapid transfer, particularly to lipoproteins, provides a mechanism for its rapid delivery to cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12753726

Source DB:  PubMed          Journal:  J Pharm Pharm Sci        ISSN: 1482-1826            Impact factor:   2.327


  15 in total

Review 1.  Scientific and Regulatory Considerations for Generic Complex Drug Products Containing Nanomaterials.

Authors:  Nan Zheng; Dajun D Sun; Peng Zou; Wenlei Jiang
Journal:  AAPS J       Date:  2017-01-23       Impact factor: 4.009

2.  Predictors and Limitations of the Penetration Depth of Photodynamic Effects in the Rodent Brain.

Authors:  Collin T Inglut; Brandon Gaitan; Daniel Najafali; Irati Abad Lopez; Nina P Connolly; Seppo Orsila; Robert Perttilä; Graeme F Woodworth; Yu Chen; Huang-Chiao Huang
Journal:  Photochem Photobiol       Date:  2019-10-13       Impact factor: 3.421

3.  Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.

Authors:  Shifalika Tangutoori; Bryan Q Spring; Zhiming Mai; Akilan Palanisami; Lawrence B Mensah; Tayyaba Hasan
Journal:  Nanomedicine       Date:  2015-09-25       Impact factor: 5.307

4.  Photodynamic Therapy Synergizes with Irinotecan to Overcome Compensatory Mechanisms and Improve Treatment Outcomes in Pancreatic Cancer.

Authors:  Huang-Chiao Huang; Srivalleesha Mallidi; Joyce Liu; Chun-Te Chiang; Zhiming Mai; Ruth Goldschmidt; Neema Ebrahim-Zadeh; Imran Rizvi; Tayyaba Hasan
Journal:  Cancer Res       Date:  2015-12-30       Impact factor: 12.701

5.  New method for delivering a hydrophobic drug for photodynamic therapy using pure nanocrystal form of the drug.

Authors:  Koichi Baba; Haridas E Pudavar; Indrajit Roy; Tymish Y Ohulchanskyy; Yihui Chen; Ravindra K Pandey; Paras N Prasad
Journal:  Mol Pharm       Date:  2007-02-01       Impact factor: 4.939

6.  Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy.

Authors:  Adam W York; Kyle R Zablocki; Daniel R Lewis; Li Gu; Kathryn E Uhrich; Robert K Prud'homme; Prabhas V Moghe
Journal:  Adv Mater       Date:  2012-01-02       Impact factor: 30.849

Review 7.  Liposomal formulations of photosensitizers.

Authors:  Sanjana Ghosh; Kevin A Carter; Jonathan F Lovell
Journal:  Biomaterials       Date:  2019-07-10       Impact factor: 12.479

8.  Photodynamic Therapy for Cancer and for Infections: What Is the Difference?

Authors:  Sulbha K Sharma; Pawel Mroz; Tianhong Dai; Ying-Ying Huang; Tyler G St Denis; Michael R Hamblin
Journal:  Isr J Chem       Date:  2012-09       Impact factor: 3.333

9.  PLGA/liposome hybrid nanoparticles for short-chain ceramide delivery.

Authors:  Peng Zou; Stephan T Stern; Duxin Sun
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

Review 10.  Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy.

Authors:  Hsin-I Chang; Ming-Kung Yeh
Journal:  Int J Nanomedicine       Date:  2011-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.